Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Jeannett Dimsits"'
Autor:
Allyson S. Hughes, Katherine Chapman, Jeoffrey Bispham, Jeannett Dimsits, Stuart Weinzimer, Wendy Wolf, Nazanin Heydarian
Publikováno v:
Journal of Clinical & Translational Endocrinology, Vol 30, Iss , Pp 100310- (2022)
Introduction: This study characterized the emotional impact of severe hypoglycemia, views of glucagon, and barriers to glucagon use from the perspective of adults with type 1 diabetes (T1D). Methods: Participants included individuals recruited from t
Externí odkaz:
https://doaj.org/article/325de37248a24c928028d852a9022c1d
Publikováno v:
Diabetes technologytherapeutics. 24(4)
BACKGROUND Severe hypoglycemic episodes are life-threatening events demanding rapid administration of glucagon by a caregiver or bystander. The glucagon analog dasiglucagon is stable in aqueous formulation and therefore suitable for delivery in a rea
Autor:
Stuart A. Weinzimer, Katherine S.M. Chapman, Nazanin M. Heydarian, Jeoffrey Bispham, Allyson Hughes, Jeannett Dimsits, Wendy Wolf
Publikováno v:
Diabetes. 70
Introduction: Severe hypoglycemia is an ongoing barrier to achieving glycemic targets. Glucagon is an effective, yet underutilized treatment for severe hypoglycemia. This study characterized the emotional impact of severe hypoglycemia, glucagon perce
Publikováno v:
Diabetes. 70
Dasiglucagon is a novel glucagon analog, stable in aqueous solution and suitable for delivery in a ready-to-use autoinjector (HypoPal®) for the treatment of severe hypoglycemia. This study was performed to assess HypoPal device handling vs. GEK duri
Autor:
Ilan Raymond, Frants Pedersen, Per Hildebrandt, Jørgen Jacobsen, Jesper Mehlsen, Jeannett Dimsits
Publikováno v:
European Journal of Heart Failure. 6:653-661
To determine the prognosis, total mortality and cardiac morbidity, of patients with left ventricular systolic dysfunction and heart failure (HF) in a general population sample.A total of 764 subjects, 432 females and 332 males, median age (range) 66
Autor:
John B. Holcomb, Richard P. Dutton, Howard R. Champion, Gordon R. Bernard, Bartholomew J. Tortella, Carl J. Hauser, Jeannett Dimsits, Bertil Bouillon, Kenneth D. Boffard, Jean Louis Vincent, Michael Parr, Martin A. Croce, Ari Leppäniemi
Publikováno v:
The Journal of trauma. 71(1)
Safety data on recombinant activated factor VII (rFVIIa, NovoSeven; Novo Nordisk A/S, Bagsværd, Denmark) in actively hemorrhaging trauma patients are limited. We present detailed safety data from a large multicenter, randomized, placebo-controlled p
Autor:
Gordon R. Bernard, Bertil Bouillon, Martin A. Croce, Jean Louis Vincent, Carl J. Hauser, Ari Leppäniemi, Jeannett Dimsits, Bartholomew J. Tortella, Kenneth D. Boffard, Michael Parr, Richard P. Dutton, John B. Holcomb
Publikováno v:
The Journal of trauma. 69(3)
Background: Traumatic coagulopathy contributes to early death by exsanguination and late death in multiple organ failure. Recombinant Factor VIIa (rFVIIa, NovoSeven) is a procoagulant that might limit bleeding and improve trauma outcomes. Methods: We